Pancreatic Cancer Research

ResearcherPeking University First HospitalNo recent work listed

Feng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2316-289X; OpenAlex author ID A5100741404. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 1 paper

Papers 1

  1. LncRNA H19-Derived miR-675-3p Promotes Epithelial-Mesenchymal Transition and Stemness in Human Pancreatic Cancer Cells by targeting the STAT3 Pathway. Co-author DOI 10.7150/jca.44833↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Long Rong · 1 shared paper, 2020 · strength 0.11
  2. Ling Ma · 1 shared paper, 2020 · strength 0.11
  3. Xiaodong Tian · 1 shared paper, 2020 · strength 0.11
  4. Zhengkui Zhang · 1 shared paper, 2020 · strength 0.11
  5. Yongsu Ma · 1 shared paper, 2020 · strength 0.11
  6. Yinmo Yang · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.